Ilka Warshawsky

1.5k citations
33 papers · 1.2k indexed · h-index 19

Ilka Warshawsky

32 papers receiving 1.1k citations

Peers

Ilka Warshawsky
Comparison fields: 5 of 92
  • Hematology 291
  • Immunology and Allergy 102
  • Cancer Research 229
  • Genetics 157
  • Immunology 238
Replace Charlotte Rorsman with:
Charlotte Rorsman Sweden
Robert Tressler United States
Karine Cohen-Solal France
R.S. Lemons United States
Ida Casella Italy
Paloma García United Kingdom
Maya Zigler United States
Tammy L. Moser United States
Daniela Talarico Italy
Tracee S. Panetti United States
Ilka Warshawsky relative to Charlotte Rorsman Sweden Charlotte Rorsman's profile →
Citations per field
00.5×1.5×1.9×
Charlotte Rorsman · 1×
Citations per year

Countries citing papers authored by Ilka Warshawsky

Since Specialization
Citations

This map shows the geographic impact of Ilka Warshawsky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ilka Warshawsky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ilka Warshawsky more than expected).

Fields of papers citing papers by Ilka Warshawsky

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ilka Warshawsky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ilka Warshawsky. The network helps show where Ilka Warshawsky may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Ilka Warshawsky, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ilka Warshawsky Line = papers co-authored together Ilka Warshawsky links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20121
2 201111
3 20093
4 200615
5 200541
6 20055
7 200530
8 200452
9 200418
10 200313
11 200232
12 20013
13 199761
14 199635
15 199560
16 199532
17 199526
18 19948
19 199496
20 199369

About Ilka Warshawsky

Ilka Warshawsky is a scholar working on Hematology, Cancer Research and Internal Medicine, having authored 33 papers that have together received 1.2k indexed citations. Recurring topics across this work include Protease and Inhibitor Mechanisms (11 papers), Blood Coagulation and Thrombosis Mechanisms (8 papers), Peptidase Inhibition and Analysis (6 papers), Signaling Pathways in Disease (3 papers), Glycosylation and Glycoproteins Research (2 papers), Blood properties and coagulation (2 papers), Chronic Lymphocytic Leukemia Research (2 papers) and Lipoproteins and Cardiovascular Health (2 papers). The work is most often cited by research in Hematology (291 citations), Immunology and Allergy (102 citations) and Cancer Research (229 citations). Ilka Warshawsky has collaborated with scholars based in United States, Germany and Ireland. Frequent co-authors include Alan L. Schwartz, Guojun Bu, Philip W. Majerus, George Broze, John D. York, Bonnie Shadrach, Ming Gu, Mark R. Wardell, Mairead Commane and Marvin R. Natowicz. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026